Health Care: Drugs

Ligand Pharmaceuticals Inc (LGND: NASDAQ)

$53.97 n/a | n/a%
10/24/14 - 03:59 PM ET
Company Cash Flow
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash Flow From Operating Activities
Net Income (Loss) 11.42M -527.00K 10.18M -10.37M
Operating Gains/Losses 5.00K -17.00K 6.00K -607.00K
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables 2.37M 1.52M -3.92M -375.00K
(Increase) Decrease in Inventories 646.00K 1.03M 1.11M 0.00
(Increase) Decrease In Other Current Assets -130.00K 515.00K 4.86M -3.93M
(Decrease) Increase In Payables -2.76M -4.80M -11.57M -13.45M
(Decrease) Increase In Other Current Liabilities 0.00 0.00 0.00 0.00
(Increase) Decrease In Other Working Capital -827.00K -1.03M 3.63M -6.98M
Other Non-Cash Items 7.16M 2.85M 6.69M 7.90M
Net Cash From Continuing Operations 21.33M 1.06M -1.17M -27.31M
Net Cash From Discontinued Operations -642.00K -900.00K 0.00 240.00K
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 20.69M 161.00K -1.17M -27.07M
Sale of Property, Plant & Equipment 3.00K 20.00K 530.00K 589.00K
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 10.00M 19.35M 54.04M
Purchases of Property, Plant & Equipment -3.95M -595.00K -78.00K -70.00K
Acquisitions 0.00 0.00 -32.02M -2.83M
Purchases of Short-Term Investments 0.00 0.00 -10.00M -35.58M
Other Cash from Investing Activities -1.03M -8.16M -2.91M -1.60M
Cash Provided by Financing Activities
Net Cash From Investing Activities -4.97M 1.26M -25.13M 14.54M
Issuance of Debt 0.00 7.50M 30.00M 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 2.97M 6.29M 54.00K 23.00K
Repayment of Long-Term Debt -19.59M -10.00M 0.00 -91.00K
Repurchase of Capital Stock 0.00 0.00 -55.00K -91.00K
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net 154.00K 124.00K 0.00 0.00
Net Cash From Financing Activities -16.46M 3.92M 30.00M -159.00K
Effect of Exchange Rate Changes 0.00 0.00 0.00 0.00
Net Change in Cash & Cash Equivalents -742.00K 5.34M 3.70M -12.69M

Portfolios with LGND

Latest LGND Headlines from TheStreet

More Financial News for LGND

Press Releases for LGND

See All Press Releases

Partner Headlines for LGND

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter